Centene

CNC · NYSE

$70.81+$2.18 (+3.18%)TodayMarket closed ·
Prev close $68.63

About CNC

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. The company is headquartered in St. Louis, Missouri and currently employs 61,100 full-time employees. The company went IPO on 2001-12-13. The company provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.

Employees
61,100
Headquarters
St. Louis, Missouri
Listed
Dec 13, 2001
Sector
Health Care
Industry
Health Care Providers & Services

CNC key statistics

Market cap
34.98B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
4.21M
Volume
3.39M
Open price
$69.07
High today
$70.97
Low today
$68.90
52 Week high
$71.21
52 Week low
$31.63

Centene (CNC) at a glance

As of Oct 20, 2026, Centene (CNC) shares are priced at $70.81, giving the company a market cap of 34.98B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $68.90 and $70.97. The current price is 2.8% above the day's low and 0.2% below its high.

Volume so far is 3.39M shares, in line with the average of 4.21M shares a day.

Over the past year Centene has ranged from $31.63 to $71.21, and now sits 99% of the way up that range.

Centene met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $2.51 per share against an estimate of $1.10.

The average analyst price target is $73.35, 3.6% above the current price, from 18 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

44%of 18 analyst ratings say Buy
  • Buy44.4%
  • Hold50.0%
  • Sell5.6%
Price target · 22 analystsAvg $73.35
Low
$56.56
Now
$70.81
High
$89.25

CNC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 105.5% on average.

  1. Q3 FY24: reported $1.62 per share against an estimate of $1.34
  2. Q4 FY24: reported $0.80 per share against an estimate of $0.4992
  3. Q1 FY25: reported $2.90 per share against an estimate of $2.57
  4. Q2 FY25: reported -$0.16 per share against an estimate of $0.8662
  5. Q3 FY25: reported $0.50 per share against an estimate of -$0.1409
  6. Q4 FY25: reported -$1.19 per share against an estimate of -$1.24
  7. Q1 FY26: reported $3.37 per share against an estimate of $2.15
  8. Q2 FY26: reported $2.51 per share against an estimate of $1.10

CNC news

  • Press releasePRNewswire

    Ambetter Health Announces 2027 Marketplace Offerings, Including Enhanced Condition-Specific Coverage Options

  • Press releasePRNewswire

    CENTENE CORPORATION TO HOST 2026 THIRD QUARTER FINANCIAL RESULTS EARNINGS CALL

  • Press releasePRNewswire

    Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma

  • Press releasePRNewswire

    PA Health & Wellness Earns National Recognition Among Top Medicaid Health Plans for Second Consecutive Year

  • Press releasePRNewswire

    Centene to Launch Nationwide Gold Card Program for Qualifying Providers

  • Press releasePRNewswire

    Ambetter Health Solutions and Marathon Health Expand Access to Primary Care for Members in Indiana and Missouri

  • Press releasePRNewswire

    Wellcare Unveils 2027 Medicare Offerings Focused on Affordability and Integrated Care

  • Piero Cingari

    Junk Bond Yields Are Back Above 15%: 10 Stocks In The Pressure Zone

Similar companies

Companies in the same industry as Centene

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.